The European Society of Cardiology heart failure guidelines firmly recommend regular physical activity and structured exercise training (ET), but this recommendation is still poorly implemented in daily clinical practice outside specialized centres and in the real world of heart failure clinics. In reality, exercise intolerance can be successfully tackled by applying ET. We need to encourage the mindset that breathlessness may be evidence of signalling between the periphery and central haemodynamic performance and regular physical activity may ultimately bring about favourable changes in myocardial function, symptoms, functional capacity, and increased hospitalization-free life span and probably survival. In this position paper, we provide practical advice for the application of exercise in heart failure and how to overcome traditional barriers, based on the current scientific and clinical knowledge supporting the beneficial effect of this intervention.
Introduction
The 2008 European Society of Cardiology heart failure (HF) guidelines firmly recommend regular physical activity and structured exercise training (ET). This recommendation is based on the fact that ET improves exercise capacity and quality of life, does not adversely affect left ventricular remodelling, and may reduce mortality and hospitalization in patients with mild-to-moderate chronic heart failure (CHF) (recommendation class I). 1 Unfortunately, this recommendation is still poorly implemented in daily clinical practice outside specialized centres and in the real world of HF clinics: in a recent survey among 673 hospitals in 43 European countries, only 63% reported to have implemented HF management programmes, and only 42% of these incorporated an exercise component. 2 Less than 20% of HF patients are participating in a cardiac rehabilitation programme according to a more recent European survey. 3 
Hazard of extending commonsense advice
In most clinical circumstances, and in most specialities, we advise patients to avoid stimuli that cause adverse symptoms. For example, a patient who gets diarrhoea with gluten-containing foods will be advised how to avoid gluten, or a patient who gets wheezing when going near a certain type of tree will be advised to avoid that tree. In HF, therefore, it is not surprising that some of our colleagues adopt this commonsense approach: if exercise causes breathlessness and other limiting symptoms, reduce exercise to a level that allows comfortable everyday life. However, scientific evidence now clearly goes against patient's and physician's intuitive prejudice.
In reality, exercise intolerance in CHF can be successfully tackled by applying ET. We need to resolve the standard clinical mindset that the occurrence of symptoms indicates that damage is being done. Instead, we need to encourage the mindset that breathlessness may be evidence of signalling between the periphery and central haemodynamic performance 4 and regular physical activity may ultimately bring about favourable changes in myocardial function, symptoms, functional capacity, and increased hospitalizationfree life span and probably survival.
In this position paper, we provide practical advice for the application of ET in HF and how to overcome traditional barriers, based on the current scientific and clinical knowledge supporting the beneficial effect of this intervention. Additional information as detailed below is provided in the Supplementary material online, Appendix: † Pathophysiology: multifactorial origin of exercise intolerance; † ET and systolic HF: a literature review; † Effects on HF with preserved ejection fraction.
How to implement exercise training
In general, both healthy and diseased subjects can increase their cardiorespiratory endurance in many ways. A lifestyle approach can be adopted to promote physical exercise together with structured ET programmes; the former approach involves the promotion of common daily activities, such as brisk walking, climbing stairs (rather than taking the lift), doing more house work and gardening, and engaging in active recreational pursuits. 5 In CHF, both approaches have been suggested; however, in the present paper only the structured physical activity (i.e. ET) approach will be discussed (as lifestyle changes are presented extensively elsewhere). 6, 7 Implementation of ET requires appropriate patient selection, training protocol identification, intensity, and progression monitoring. These issues have mainly been addressed in stable HF patients, and a summary of available knowledge will be provided later. However, since in daily practice we also have to prescribe ET in acute HF patients, in the next chapter, we will provide a preparatory scheme for initiating ET in this setting.
Patient selection
Exercise training is recommended for stable New York Heart Association (NYHA) class I -III HF patients. Although conventional wisdom and data derived from existing clinical studies exclude the role of exercise in the management of advanced or acute HF patients, we believe that after hospitalization for exacerbation, early mobilization through an individualized exercise programme may prevent further disability and lay good foundations for the formal ET plan.
The transition phase in the course of clinical stabilization from forced rest to the initiation of ET has been poorly described and investigated. A flow-chart is proposed here to guide the healthcare (HC) provider and physician in tailoring the exercise advice according to the individual clinical condition and needs of the patient (Figure 1 ). This flow-chart covers several critical clinical and functional turning points that need to be addressed before starting regular formal ET.
Both clinical stability and early mobilization are important requisites that help achieve functional self-sufficiency and trust prior to conducting a symptom-limited exercise test and initiating regular ET. In this phase, gradual mobilization/calisthenics, respiratory training, and small muscle strength exercise can be considered alone or in combination. Each exercise modality should be tested in the individual HF patient, to verify clinical and haemodynamic tolerance, ascertain acceptability, and prove safety. Accordingly, this phase should be extremely flexible in terms of temporal and modality development.
When clinical stabilization is achieved, appropriate screening for contraindications to exercise is necessary, including medical history, clinical examination, resting electrocardiogram (ECG), a symptom-limited exercise test, and echocardiography ( Table 1) . If the clinical status of a patient is unclear and/or previous examinations/tests are inconclusive, supplementary investigations such as 24 h Holter ECG monitoring, chest X-ray, or stress echocardiography should be considered as appropriate.
Finally, the selection of the exercise modality should take into account the patient's age, concomitant disease(s), leisure and working habits, preferences and abilities, logistical restraints, and the availability of ET facilities and equipment.
Gradual mobilization
A gentle individualized gradual mobilization of the patient (known as 'calisthenic exercises') is advisable as a prologue and preparatory form of exercise, especially for severe HF patients with physical deconditioning or cachexia or after recent clinical instability. A variety of simple movements, performed without weights or equipment, intended to increase body strength and flexibility using the weight of one's own body for resistance, in combination with stretches, are advisable in these conditions. These movements should be initiated as soon as possible, since they are easy to perform and well accepted. They improve movement co-ordination and respiratory capacity.
Selection of the optimal training protocol
Identification of the appropriate and adequate level of training intensity is crucial to obtain the desired benefits while maintaining reasonable control of the related risk. A universal agreement on exercise prescription in CHF does not exist; thus, an individualized approach is recommended, with careful clinical evaluation, including behavioural characteristics, personal goals, and preferences.
Training protocols vary in a number of variables: 8 intensity (aerobic and anaerobic); type (endurance, resistance, and strength), method (continuous and intermittent/interval), application (systemic, regional, and respiratory muscle), control (supervised and Exercise training in heart failure: from theory to practice non-supervised), and setting (hospital/centre-and home-based). Three different training modalities have been proposed with different combinations: 9 (1) endurance aerobic (continuous and interval); (2) strength/resistance; (3) respiratory.
Endurance aerobic training (continuous and interval)
Continuous endurance training Continuous aerobic training is typically performed at moderateto-high exercise intensities in steady-state conditions of aerobic energetic yield, which allows the patient to perform prolonged training sessions (up to 45-60 min duration). It is the best described and established form of training, because of its welldemonstrated efficacy and safety, and is thus highly recommended in the guidelines. 1 It is well accepted since it is easily taught and performed by patients, usually on a cycle ergometer or a treadmill. In more deconditioned patients, it is recommended to start low and go slow (i.e. at low intensity for 5-10 min twice a week). If well tolerated, first the training duration per session and then the numbers of sessions per day are increased, aiming at 20 -60 min on 3-5 days per week at moderate-to-high intensity with indefinite programme duration.
The gold standard method for exercise intensity assessment is the use of directly determined physiological descriptors of metabolic effort intensity, i.e. peak oxygen consumption (VO 2 peak), by symptom-limited cardiopulmonary exercise test. Thus training intensity is usually prescribed relative to VO 2 peak, VO 2 reserve (VO 2 R) (i.e. the difference between the basal and VO 2 peak), or at the anaerobic threshold (when clearly detected). Recommended training intensities are 40-50% at the starting point, increasing to 70 -80% of the percentage VO 2 peak or VO 2 R.
Since cardiopulmonary exercise testing is not always available in routine clinical practice, indirect methods have been proposed for monitoring metabolic work during a conventional stress test or a 6 min walking test, such as heart rate (HR) or HR reserve (HRR ¼ difference between the basal and peak HR) and rating of perceived exertion (RPE). A 'training HRR range' of 40 -70% HRR and 10/20 -14/20 of the Borg RPE are recommended. 6 Interval endurance training Recently, interval (or intermittent) training has been proposed to be more effective than sessions of continuous exercise for improving exercise capacity. In contrast with the continuous training protocol, the patient is asked to alternate short bouts (10 -30 s) of moderate-high intensity (50 -100% peak exercise capacity) exercise, with a longer recovery (80 -60 s) phase, performed at low or no workload.
Typically high-and low-intensity interval training programmes are available according to the patient's capabilities. High-intensity programmes have been performed by patients walking on a treadmill at band speeds. Each session included four 4 min bouts of highintensity exercise (corresponding to 90-95% of their maximal exercise capacity), interspersed with 3 min recovery periods at low intensity, plus 5-10 min of warm-up and cool-down. 10 -12 Low-intensity interval training programmes can be performed on an electrically braked cycle ergometer, which maximizes control over the patient's workload. The hard and recovery segments are 30 and 60 s in duration, respectively, and the hard segments are accomplished at 50% of the power output achieved during a ramp test or an incremental bicycle test with 10 W × 1 min increments. If the patient has trouble tolerating a 15 min training bout using this work/recovery ratio, the durations of the segments can be adjusted to a 20/70 s ratio, respectively, or even to 10/80 s if necessary. Typically, the intensity of the first three hard segments is reduced to allow for warm-up. As the patient becomes better conditioned, the intensity of the hard segments should be increased accordingly. Depending on the work/ recovery interval chosen, 10-12 work phases can be performed per 15 -30 min training session.
Resistance/strength training Resistance/strength training (RST) is a muscle contraction performed against a specific opposing force thereby generating resistance, such as lifting weights. It gradually and progressively overloads the musculoskeletal system, so it strengthens and tones muscles and increases bone mass and has been proposed as an anabolic intervention to help prevent the wasting syndrome. Functional alterations in the skeletal muscle are considered an important determinant of exercise intolerance in CHF. Furthermore, ageing is associated with a continuous decline in skeletal muscle mass, which is why elderly HF patients are at particular risk of muscle wasting. 13 Resistance/strength training should be considered in these patients.
Although earlier concerns about a detrimental effect on left ventricular function and negative remodelling caused by increased afterload during the lifting phase of RST have not been confirmed, 14 the current peer-reviewed evidence remains controversial with regard to a general recommendation to implement RST as an exercise modality for patients with CHF, due to the superiority of endurance training on parameters of exercise capacity and left ventricular function. In this regard it is important to realize that endurance exercise remains the mainstay in CHF patients and that RST can reasonably complement but not substitute. The amount of cardiovascular stress expected during RST depends on the magnitude of the resistance [% of one repetition maximum (% 1-RM), i.e. the maximum weight that can be lifted only once], the size of the working muscle mass and finally the relation between the duration of the muscle contraction and rest period between repetitions. The pressure load will be lower the smaller the resistance (% 1-RM), the shorter the contraction period (1-3 s), and the longer the resting period between contractions. In advanced CHF or in patients with a very low exercise tolerance, RST can be safely applied if small muscle groups are trained, short bouts of work are applied, and the number of repetitions is limited with a work/recovery duration ratio of at least 1:2. The use of elastic bands (Thera-Band w ) is also very suitable, but difficult to quantify.
To allow for maximal safety, initiation of an RST programme must be individually adapted to the patient by an experienced exercise therapist under medical supervision and each patient must be individually introduced into the training regimen. The minimum recommendations for the implementation of an RST are summarized in Table 2 , where three progressive steps are described: 15 (1) 'Instruction phase': a preliminary step should be performed, to get the patient well accustomed to the modality of the exercise, and for intermuscular co-ordination and physical perception. These preparatory exercises must be conducted slowly, without or at a very low resistance (,30% 1-RM) until the patient is confident with the course of the movements. (2) 'Resistance/endurance phase': RST can be started with a high number of repetitions (12 -25) and a low intensity (30-40% 1-RM), corresponding rather to a combination of endurance and resistance because of a low haemodynamic load. When the patient is confident with the exercise, he can proceed to the next phase (strength phase). (3) 'Strength phase': RST at higher intensity (40-60% 1-RM) in order to increase muscle mass.
During each step, the danger of the abdominal straining (Valsalva manoeuvre) and consequent blood pressure elevations should be emphasized and special attention must be paid to prescribing the appropriate level of training according to the patient's motivation level, personality, and previous experience with RST.
Determination of the intensity of resistance training For determination of the training intensity, a maximal strength test (i.e. 1-RM) is in general unsuitable for CHF patients because it leads to Valsalva manoeuvre. Instead a graded stress test can be applied; the training intensity should be set at the level of resistance at which the patient can perform 10 repetitions without abdominal straining and without symptoms. When assessing the load for a patient, the Borg RPE scale provides the patient's own subjective stress perceptions in addition to measured physiological parameters. The load can be increased progressively according to the Borg scale: in patients with moderate risk, stress perception should be at a maximum RPE of 15.
16
Respiratory training Trials using inspiratory muscle training in CHF patients suggest that such an intervention can improve exercise capacity and quality of life, particularly in those who present with inspiratory muscle weakness (IMW). 17 Hence, routine screening for IMW is advisable and specific inspiratory muscle training in addition to standard endurance training might be beneficial. 1-RM, one repetition maximum; RPE, rating of perceived exertion.
Exercise training in heart failure: from theory to practice It has been suggested to start respiratory training at 30% of the maximal inspiratory mouth pressure (PI max ) and to readjust the intensity every 7-10 days up to a maximum of 60%. 18 Training duration should be 20 -30 min/day with a frequency of 3-5 sessions per week for a minimum of 8 weeks. In order to optimize the effect, it should be considered that any training stimulus, being specific to the inspiratory muscles or not (such as aerobic muscle training alone), may improve inspiratory muscle strength and functional capacity in patients with IMW. Thus in patients without IMW, high-intensity inspiratory muscle training may be necessary to affect functional capacity. Several different protocols and devices have been used for inspiratory muscle training in different clinical settings, including isocapnic hyperpnoea, incentive spirometry, resistive pressure threshold load, and computer-controlled biofeedback trainers. Most studies in CHF have used the Threshold Inspiratory Muscle Trainer (Respironics Health Scan, Inc., Cedar Grove, NJ, USA), but when inspiratory muscle strength is preserved, devices with potential to reach higher inspiratory pressures such as the PowerBreathe (HaB International Ltd, Southam, Warwickshire, UK) might be used. These hand-held devices are relatively inexpensive and therefore permit home training. The efficacy of computercontrolled biofeedback is currently under investigation.
A general guide to proposed indications for the prescription of different training modalities (continuous endurance, interval endurance, resistance/strength, and respiratory) in stable CHF patients according to exercise capacity and clinical characteristics is given in Table 3 . Arbitrary cut-points are proposed for age (, or ≥65 years) and activity habits (mainly sedentary or not). Table 4 summarizes the main characteristics of each form of training (endurance, interval, strength, and respiratory). Variables of interest, how to start, progression of training, optimal intensity target, exercise capacity, haemodynamic effects, respiratory effects, peripheral and other effects, advantages, limitations, safety, and setting are shown for each form of training.
Setting: hospital based vs. home based
Traditionally, HC for patients with CHF has concentrated on supervised and centre-based programmes. On the one hand, these are safe and effective, and offer optimal conditions of care; on the other hand, they are resource intensive and of limited availability. Moreover, the main issue is not the short-term efficacy but the preservation of the gained benefits over time; the principal aim is for the patient to remain active for an indefinite period of time. Thus the key to optimal long-term benefits is the identification of strategies to motivate patients to continue with exercise at home. To avoid rapid deterioration of the progress that has been achieved during a structured, supervised programme, a gradual transition to a home-based programme is necessary. 19 However, it is recommended to start training in a setting of direct monitoring and supervision, especially during initial sessions and particularly when HF symptoms are severe. A supervised programme also allows for education, and close control of adherence to the prescribed therapies and provides reassurance for the patient. Stable and well-treated patients could initiate a home-based programme after a baseline exercise test with guidance and instructions. Frequent follow-up can help assess the benefits of the home exercise programme, determine any unforeseen problems, and will allow the patient to advance to higher levels of exertion if lower levels of work are well tolerated.
Specific population: patients with implantable cardioverter defibrillators and/or cardiac resynchronization therapy
The literature about exercise in patients with an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) device is limited. However, a lot of centres are offering cardiac rehabilitation programmes for such patients and the actual evidence shows that ET can be performed safely. One randomized study reported a reduction of the number of ICD discharges in the training group and showed that the presence of non-sustained ventricular tachycardia in the presence of an ICD does not constitute a contraindication for aerobic ET. 20 The potential benefits of an ET programme after ICD implantation are numerous and include familiarization with the device, instruction about physical activity, psychological support, and improvement of exercise capacity if the patient suffers from exercise intolerance. It has been demonstrated that ET in CRT patients can almost double their improvement in exercise capacity and further improve haemodynamic measures and quality of life. 21, 22 As the basis for exercise advice and prescription, a symptomlimited cardiopulmonary exercise stress test is mandatory before ET is started. In ICD patients, the information from such a test 
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Exercise training in heart failure: from theory to practice goes beyond the diagnosis of ischaemia or the determination of exercise capacity. Especially important is the chronotropic response to exercise, the presence of exercise-induced arrhythmias, HR in case of onset of an arrhythmia, the effectiveness of pharmacological HR control, and the risk of reaching an HR in the ICD intervention zone. Furthermore, such a test should help reassure the patients and their physician.
In general, ICD patients should start ET under medical supervision and the HR should be monitored, if the protocol is intended to bring the HR near the device's programmed intervention zone. Patients having experienced symptomatic arrhythmias or ICD discharges should be directed towards exercise modalities in which a short loss of consciousness due to ICD discharge might be less harmful, for example avoiding strenuous swimming or climbing heights. Theoretically, pronounced arm-shoulder movements or intense mechanical strain of the ICD pouch could also trigger inappropriate ICD shocks, but in giving advice we should be careful not to add to the list of reasons for patients to avoid exercise. Exercise level, and/or ICD programming, can be arranged to keep the maximal HR 20 beats below the ICD intervention zone.
The staff caring for ICD patients need to be made aware of the following information to reduce the risk of incidents: the underlying heart disease and the reason for ICD implantation, the triggers of arrhythmia (ischaemia and specific HR), the arrhythmic substrate, the ICD intervention HR, and the sequence of therapy (monitoring zone, anti-tachycardia pacing, and shocks). The staff should express confident understanding of the purpose of the device and that this increases, rather than decreases, safety of the patient. In case of any intervention of the device, the causes should be assessed and any changes in device programming, medications, or exercise regime should be considered. Exercise should be started again swiftly after the device interrogation to avoid the ICD discharge becoming a psychological block on future activity.
Barriers to clinical application of exercise training recommendations
In addressing adherence to application of exercise recommendations, two aspects need to be considered: firstly the adherence of HC providers to clinical guidelines (guideline adherence) and secondly the adherence of the patient to the advice of the clinician (patient adherence) ( Table 5) .
Guideline adherence by health-care providers
Adhering to the guidelines is a predictor of outcome in CHF; however, guideline adherence remains far from optimal regarding prescription of recommended medications and also regarding non-pharmacological treatment, including exercise. 23 Barriers for practitioners to recommend ET are related to the individual professional, the HC team, and the HC organization. 24 For example, poor knowledge of the HC providers about the effect of exercise might be one reason; thus, better information about the evidence base might promote better guideline adherence. The lack of availability of ET sites or the absence of financial Safety (Supervision is mandatory during the initial phase. Continuous or frequent clinical monitoring is also fundamental, particularly during the home training phase) Safety is good, if progression of exercise is based on an individualized prescription that is gradual and pyramidal in nature A proper training programme set-up needs a close assessment of exercise intensity and work-volume for early detection of adverse effects. In addition, with the use of ECG monitoring, rhythm disorders can be detected Setting In-and out-hospital (in a fitness centre for the less diseased patients and in the maintenance stage)
VAT, ventilatory anaerobic threshold; SBP, systolic blood pressure.
Exercise training in heart failure: from theory to practice reimbursement for enrolment of CHF patients in cardiac rehabilitation programmes can play a crucial role: organizational and political measures are needed. By integrating exercise programmes into existing HF management programmes and making referral an integral part of quality assessment of HF management, ET might be prescribed more often.
Patient adherence to treatment recommendations
Patient adherence is a multidimensional phenomenon, determined by the interplay of a set of five dimensions: social and economic factors, factors related to the HC system, factors related to the patients' condition, the therapy, and the patients themselves. 25 Data on rehabilitation in cardiac patients show that compliance to exercise is ,50%: older age, lower socioeconomic status, female gender, psychological characteristics (such as depression), lack of motivation, and financial and medical concerns are the main determinants. 26 Additional reasons specific for CHF are the presence of physical symptoms and lack of energy. 27 This was confirmed by the results of the HF-ACTION trial, in which only 29 -42% of the patients were performing ET as prescribed after 3 months. Chronic HF patients need additional strategies to improve their adherence, which should be targeted at the barriers affecting the individual patient (such as adapting the programme to fit in with the patient's working schedule), the HC system (e.g. financial compensation), or organization of social support.
Home-based cardiac rehabilitation, using telemedicine, may help overcome some of the above-mentioned barriers 28 (see Supplementary material online, Appendix).
Conclusion: a long way to go. . .
Although much has already been achieved, there is a great deal more that we need to learn about ET. We need to know more about patient groups who are more like the patients seen in everyday clinical practice, rather than the patients who volunteer for studies. This is difficult because, by definition, it means studying patients (such as women, the elderly, and minority groups) who are often excluded from clinical trials. We also need more effective methods to improve adherence and compliance in the long term.
Patients who readily promise to adhere in advance sometimes deliver on these promises in the short term, but often cannot sustain such behavioural changes. We also need better measurements of the beneficial effects of ET, to show to patients. We need to develop streamlined ways of implementing ET on an outpatient basis, beyond the laboratories that have a special interest in exercise. In summary, to paraphrase the late Philip Poole-Wilson, 'how can we persuade people to exercise, and what form of exercise?' Otherwise, evidence gained can only be translated to a small fraction of our patients.
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